Format

Send to

Choose Destination
Biochim Biophys Acta. 2013 Sep;1832(9):1421-36. doi: 10.1016/j.bbadis.2013.03.012. Epub 2013 Mar 21.

Rodent models of amyotrophic lateral sclerosis.

Author information

1
MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology, London, WC1N 3BG, UK. p.mcgoldrick@ucl.ac.uk

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterised by the degeneration of upper and lower motor neurons. Recent advances in our understanding of some of the genetic causes of ALS, such as mutations in SOD1, TARDBP, FUS and VCP have led to the generation of rodent models of the disease, as a strategy to help our understanding of the pathophysiology of ALS and to assist in the development of therapeutic strategies. This review provides detailed descriptions of TDP-43, FUS and VCP models of ALS, and summarises potential therapeutics which have been recently trialled in rodent models of the disease. This article is part of a Special Issue entitled: Animal Models of Disease.

PMID:
23524377
DOI:
10.1016/j.bbadis.2013.03.012
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center